In Depth 27 Jun 2025
Psychedelics sans side effects: neuroplastogens gain ground
The past year has seen several developments in the neuroplastogens field, including Elkedonia’s seed funding to address neuropsychiatric disorders.
About
Having completed a master’s programme in International Journalism from Cardiff University in 2022, I have written about various subjects including culture, politics, social justice, mental health, LGBTQ+ issues and gender. My undergraduate degree in life sciences has equipped me to explore my passion for reporting on health, science and the environment. When I’m not transcribing interviews and fretting about deadlines, I like to spend my time reading, watching movies, and making lousy mixtapes for a potential side career in rap music.
Articles by Roohi Mariam Peter
In Depth 25 Jun 2025
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
In Depth 20 Jun 2025
Stem cell therapy: a potential cure for hearing loss?
As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.
In Depth 11 Jun 2025
Can gene therapy treat vision loss?
Since the approval of Luxturna, there has been a wave of companies developing treatments with the potential to cure different forms of genetic blindness.
News and Trends 9 Jun 2025
First antibiotic in 50 years to tackle superbug nears approval: what’s going on in the field?
Antibiotic development has seen a slump in recent decades. Now, after 50 years, a new antibiotic has been created to tackle bacterial infections.
News and Trends 4 Jun 2025
ASCO 2025: key highlights in cancer therapeutics
Discover the major highlights from ASCO, according to researchers and drug developers who attended the convention.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 2 Jun 2025
Top biotech deals in May 2025
Learn about May 2025’s top biotech deals, featuring major collaborations in RNA interference technology, small molecules, and antibodies.
In Depth 28 May 2025
Myasthenia gravis treatments: what’s on the horizon?
Following FDA approval of Imaavy, we explore promising biotech candidates in development for myasthenia gravis.
In Depth 26 May 2025
European biotech: trends to watch in 2025
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global policies.
News and Trends 21 May 2025
Layoffs in the US: what is going on with genomics companies?
Genomics companies have been slashing jobs and culling programs in the US. Learn about the layoffs that have struck the industry in 2025.
News and Trends 19 May 2025
Will Europe become the new home for US researchers affected by policy shifts?
The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding in a move to attract U.S. researchers.
Best in Biotech 13 May 2025
Nine biotech companies in Montreal to keep an eye on in 2025
Discover nine of the hottest biotech companies in Montreal that are advancing preclinical and clinical research.
ADVERTISEMENT
